Literature DB >> 3220093

Urinary excretion of frusemide and its metabolites in a diabetic nephropathy patient.

H Nakahama, Y Orita, M Izumi, Y Fukuhara, T Kamada, Y Miwa, A Yamaji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3220093     DOI： 10.1007/bf00555520

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.

Authors:  F Andreasen; C K Christensen; F K Jakobsen; C E Mogensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-09

2.  The urinary excretion of frusemide and its metabolites by kidney transplant patients.

Authors:  H Nakahama; Y Miwa; A Yamaji; Y Orita; Y Fukuhara; M Yanase; T Kamada; T Sonoda; M Ishibasi; Y Ichikawa
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

Authors:  D E Smith; E T Lin; L Z Benet
Journal:  Drug Metab Dispos       Date:  1980 Sep-Oct       Impact factor: 3.922
  3 in total
  1 in total

Review 1.  Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

Authors:  L L Ponto; R D Schoenwald
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.